Page last updated: 2024-10-25

r 59022 and Brain Neoplasms

r 59022 has been researched along with Brain Neoplasms in 1 studies

R 59022: diacylglycerol kinase inhibitor; structure given in first source; platelet activator factor antagonist

Brain Neoplasms: Neoplasms of the intracranial components of the central nervous system, including the cerebral hemispheres, basal ganglia, hypothalamus, thalamus, brain stem, and cerebellum. Brain neoplasms are subdivided into primary (originating from brain tissue) and secondary (i.e., metastatic) forms. Primary neoplasms are subdivided into benign and malignant forms. In general, brain tumors may also be classified by age of onset, histologic type, or presenting location in the brain.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dominguez, CL1
Floyd, DH1
Xiao, A1
Mullins, GR1
Kefas, BA1
Xin, W1
Yacur, MN1
Abounader, R1
Lee, JK1
Wilson, GM1
Harris, TE1
Purow, BW1

Other Studies

1 other study available for r 59022 and Brain Neoplasms

ArticleYear
Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers.
    Cancer discovery, 2013, Volume: 3, Issue:7

    Topics: Apoptosis; Brain Neoplasms; Cell Line, Tumor; Diacylglycerol Kinase; Gene Expression Regulation, Neo

2013